colorectal serrated polyps
Conditions
Interventions
sulindac(300mg/day)
Sponsors
Department of gastroenterology and oncology institute of health biosciences the university of tokushima graduate school
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Candidate patients have to meet all the following inclusion criteria to participate in the study. #Patients with at least one colorectal serrated polyps as confirmed by histological diagnosis. #Patients with known history of all endoscopic treatments of colorectal tumor. #Patients who have undergone total colonoscopy at least one.
Exclusion criteria
Exclusion criteria: #Patients currently taking antithrombotics such as Bayasupirin,Bufferin,Panaldine,Warfarin and Persantin. #Patients with familial colorectal adenoma # Patients with a history of treatment of gastric or duodenal ulcer(those with successful eradication of Helicobacter pylori and ulcer resolution at S2 are allowed to participate in the study) #Patients with any existing cancer at the time of participate in the study # Patients with known allergy to NSAIDs # Patients currently taking anticancer drugs #Women who are or may be pregnant during the study period. # Patients currently taking NSAIDs at least 3 times weekly, for example,as analgesic.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Number and size of colorectal serrated polyps two years later | — |
Countries
Japan
Outcome results
None listed